X-17800959-C-T
Position:
Variant summary
Our verdict is Likely benign. Variant got -6 ACMG points: 0P and 6B. BP4_ModerateBS2
The NM_021785.6(RAI2):c.1052G>A(p.Arg351Gln) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000769 in 1,208,887 control chromosomes in the GnomAD database, with no homozygous occurrence. There are 40 hemizygotes in GnomAD. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Genomes: 𝑓 0.00013 ( 0 hom., 3 hem., cov: 22)
Exomes 𝑓: 0.000071 ( 0 hom. 37 hem. )
Consequence
RAI2
NM_021785.6 missense
NM_021785.6 missense
Scores
2
5
10
Clinical Significance
Conservation
PhyloP100: 3.33
Genes affected
RAI2 (HGNC:9835): (retinoic acid induced 2) Retinoic acid plays a critical role in development, cellular growth, and differentiation. The specific function of this retinoic acid-induced gene has not yet been determined but it may play a role in development. The chromosomal location of this gene designates it to be a candidate for diseases such as Nance-Horan syndrome, sensorineural deafness, non-specific X-linked cognitive disability, oral-facial-digital syndrome, and Fried syndrome. Alternate splicing results in multiple transcript variants. [provided by RefSeq, Feb 2010]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Likely_benign. Variant got -6 ACMG points.
BP4
Computational evidence support a benign effect (MetaRNN=0.119393885).
BS2
High Hemizygotes in GnomAd4 at 3 gene
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
RAI2 | NM_021785.6 | c.1052G>A | p.Arg351Gln | missense_variant | 2/2 | ENST00000451717.6 | NP_068557.4 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
RAI2 | ENST00000451717.6 | c.1052G>A | p.Arg351Gln | missense_variant | 2/2 | 1 | NM_021785.6 | ENSP00000401323 | P1 |
Frequencies
GnomAD3 genomes AF: 0.000135 AC: 15AN: 111185Hom.: 0 Cov.: 22 AF XY: 0.0000899 AC XY: 3AN XY: 33375
GnomAD3 genomes
AF:
AC:
15
AN:
111185
Hom.:
Cov.:
22
AF XY:
AC XY:
3
AN XY:
33375
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.0000875 AC: 16AN: 182918Hom.: 0 AF XY: 0.000163 AC XY: 11AN XY: 67402
GnomAD3 exomes
AF:
AC:
16
AN:
182918
Hom.:
AF XY:
AC XY:
11
AN XY:
67402
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.0000711 AC: 78AN: 1097702Hom.: 0 Cov.: 31 AF XY: 0.000102 AC XY: 37AN XY: 363102
GnomAD4 exome
AF:
AC:
78
AN:
1097702
Hom.:
Cov.:
31
AF XY:
AC XY:
37
AN XY:
363102
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.000135 AC: 15AN: 111185Hom.: 0 Cov.: 22 AF XY: 0.0000899 AC XY: 3AN XY: 33375
GnomAD4 genome
AF:
AC:
15
AN:
111185
Hom.:
Cov.:
22
AF XY:
AC XY:
3
AN XY:
33375
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Bravo
AF:
ESP6500AA
AF:
AC:
0
ESP6500EA
AF:
AC:
1
ExAC
AF:
AC:
15
ClinVar
Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Apr 13, 2022 | The c.1052G>A (p.R351Q) alteration is located in exon 3 (coding exon 1) of the RAI2 gene. This alteration results from a G to A substitution at nucleotide position 1052, causing the arginine (R) at amino acid position 351 to be replaced by a glutamine (Q). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
BayesDel_addAF
Benign
T
BayesDel_noAF
Benign
CADD
Uncertain
DANN
Pathogenic
DEOGEN2
Benign
.;T;T;T;T
FATHMM_MKL
Uncertain
D
LIST_S2
Benign
D;.;.;.;D
M_CAP
Pathogenic
D
MetaRNN
Benign
T;T;T;T;T
MetaSVM
Benign
T
MutationAssessor
Uncertain
.;M;M;M;M
MutationTaster
Benign
D;D;D;D;D
PrimateAI
Uncertain
T
PROVEAN
Benign
N;N;N;N;N
REVEL
Benign
Sift
Uncertain
D;D;D;D;D
Sift4G
Uncertain
D;D;D;D;D
Polyphen
1.0
.;D;D;D;D
Vest4
MVP
MPC
0.15
ClinPred
T
GERP RS
Varity_R
gMVP
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at